🔗 Permalink

Inventor profile of:

Dan Peer

City:

Kiryat Ono

Country:

Israel

Published Applications:

Last publication date:

2025-05-22

Top Assignees for applications by Dan Peer

The entities that hold a legal rights for patent applications filed by inventor Peer Dan:

Ramot at Tel-Aviv University Ltd. 16 Tel-Aviv, Israel
IMMUNE DISEASE INSTITUTE, INC. 4 Boston, MA United States
QUIET THERAPEUTICS LTD. 1 Ness Ziona, Israel
B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD. 1 Beer Sheva, Israel
Tel Aviv University Future Technology Development L.P. 1 Tel-Aviv, Israel
QBI ENTERPRISES LTD. 1 Nes Ziona, Israel

Recent patent applications by Peer Dan

Dan Peer from Kiryat Ono, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-22

US20250162978A1

Chemistry; metallurgy

CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF

#2 | 2024-07-25

US20240246898A1

Chemistry; metallurgy

CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF

#3 | 2023-10-05

US20230312745A1

Chemistry; metallurgy

MODULAR PLATFORM FOR TARGETED THERAPEUTICS

#4 | 2021-04-15

US20210108228A1

Chemistry; metallurgy

Method for treatment of a leukocyte related disease by delivery of nucleic acid molecules to leukocytes using targeted lipid particles

#5 | 2020-04-02

US20200101198A1

Human necessities

OMENTUM BASED SCAFFOLD AND DELIVERY SYSTEM

#6 | 2020-04-02

US20200101170A1

Human necessities

Immunoparticles and methods of generating and using same

#7 | 2019-10-10

US20190309087A1

Chemistry; metallurgy

Modular platform for targeted therapeutics

#8 | 2019-09-26

US20190292130A1

Chemistry; metallurgy

Cationic lipids for nucleic acid delivery and preparation thereof

#9 | 2018-05-24

US20180142261A1

Chemistry; metallurgy

Targeted lipid particles for systemic delivery of nucleic acid molecules to leukocytes

#10 | 2018-01-04

US20180000990A1

Human necessities

OMENTUM BASED SCAFFOLD AND DELIVERY SYSTEM

#11 | 2017-05-25

US20170143641A1

Human necessities

Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof

#12 | 2017-05-11

US20170128367A1

Human necessities

Liposomal formulations for delivery of nucleic acids

#13 | 2015-12-24

US20150366979A1

Human necessities

Positively charged polysaccharides for RNA transfection

#14 | 2015-09-03

US20150246135A1

Human necessities

Immunoparticles and methods of generating and using same

#15 | 2015-08-06

US20150216998A1

Human necessities

ENDO180-TARGETED PARTICLES FOR SELECTIVE DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS

#16 | 2015-07-23

US20150202348A1

Human necessities

OMENTUM BASED SCAFFOLD AND DELIVERY SYSTEM

#17 | 2015-05-21

US20150140108A1

Human necessities

Lipidated glycosaminoglycan particles for the delivery of nucleic acids

#18 | 2014-06-12

US20140161896A1

Human necessities

PARTICLES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

#19 | 2013-05-23

US20130129752A1

Chemistry; metallurgy

TARGETED DELIVERY TO LEUKOCYTES USING PROTEIN CARRIERS

#20 | 2012-05-24

US20120129916A1

Human necessities

Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof

#21 | 2011-07-21

US20110177155A1

Human necessities

METHODS OF DELIVERY OF AGENTS TO LEUKOCYTES AND ENDOTHELIAL CELLS

#22 | 2010-11-11

US20100285002A1

Chemistry; metallurgy

TREATMENT OR PREVENTION OF INFLAMMATION BY TARGETING CYCLIN D1

#23 | 2010-01-14

US20100008937A1

Chemistry; metallurgy

TARGETED DELIVERY TO LEUKOCYTES USING NON-PROTEIN CARRIERS

#24 | 2008-10-09

US20080248092A1

Human necessities

Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostic and therapy

InventorID:

260890 ⎘